<1079> Good Storage and Distribution Practices

Size: px
Start display at page:

Download "<1079> Good Storage and Distribution Practices"

Transcription

1

2 <1079> Good Storage and Distribution Practices Desmond Hunt, Ph.D. Principal Scientific Liaison September 7, 2017 Mexico City, Mexico

3 Good Distribution Practice Activities Suppliers Procuring, holding, storing, selling, importing, exporting, or movement of pharmaceutical materials or products The Goal To maintain the integrity of drug products throughout the supply chain To ensure drug products reach the end user with their safety, identity, strength, quality, and purity intact Manufacturers Wholesale/ Distributors Pharmacies/ Hospitals Provide evidence that drug products are stored and shipped according to labeled storage conditions GOOD DISTRIBUTION PRACTICES Healthcare Providers Patient s

4 Good Distribution Practice Environmental Control Temperature Relative Humidity Light Importation and Exportation Procurement of authentic and quality materials and products Supply Chain Integrity and Security Oxygen Shock Vibration Adulteration, counterfeited, misbranded, expired Theft and diversion

5 <1079> Good Storage and Distribution Practices <1083> Good Distribution Practices (2013 Proposal Cancelled) Environmental Control Importation and Exportation Supply Chain Integrity and Security <1079> Good Storage and Distribution Practices (Official) Introduction Labeling Information Quality Management System Good Documentation Practices Storage Management System Distribution Management System Environmental Management System Risk Management System

6 <1079> Good Storage and Distribution Practices <1079> Good Storage and Distribution Practices Focus Storage and Transportation of Finished Drug Products All organizations and individuals involved in the storage and transportation of drug products Risk-Based Approach to the Storage and Transportation of Drug Products Risk Identification Mitigation Strategies

7 Risk-based Approach to Storage and Transportation Quality Management System Documentation Training Qualification/Validation Instructions, Schedules and Records INFORMATION Competence Development and Instructions Understanding COMPREHENSION Ensure suitability of the purpose Warehouse/Packaging System/Transportation ASSURANCE Mitigation Strategies Resources Capability through infrastructure and human resources MATERIALS Risk Identification The central idea is having a Quality System that is build based on risk. Generally, mitigation strategies are related to instructions (SOPs), training (ensure instructions understanding) and Qualification/Validation (warehouse temp map, packaging system, ERP software, process validation (in case of distribution, is the transport mode/route validation).

8 Risk Identification Product and process knowledge is the starting point in identifying risks related to the storage and transportation. Product knowledge: Intended use Storage conditions Potential hazards (to environment and personnel, e.g. hormones, cytotoxic drug products, radiopharmaceuticals, etc.) Inherent vulnerability (e.g. high potential of abuse; high value drugs; attractiveness cargo theft, counterfeiting, diversion. Process knowledge: Knowledge of supply chain partners Physical modes of transportation (air, sea, rail, or road) Transportation routes

9 Risk Identification Risk identification is the systematic use of information to identify potential sources of harm (hazards). Information can include historical data, theoretical analysis, informed opinions, product and process knowledge and the concerns of stakeholders. Risk identification addresses the what might go wrong? question.

10 Identified Risk RISK EFFECT Storage Improper entry to materials management systems: (wrong batch number, wrong expiration date, wrong status e.g. approved product that should be quarantined); wrong amount) Cannot have an accurate information of the stock Can pick and ship a product that was supposed to be quarantined but due to wrong status was marked as approved Product has been stored in the wrong physical location Picking issue mistakes (software will show the location however you can pick the wrong product if there is no check of physical placement) Product can face excursions Legal sanctions for Controlled Substance Risk of diversion for Controlled Substance

11 Identified Risk RISK Storage outside of labeled specification Temperature Monitoring Device Failure Storage EFFECT Affects product quality, integrity and patient safety (e.g. freezing of vaccine or biologic) Product loss (e.g. money) Out-of-range cold or hot areas; Product storage temperature excursion; Storage /Temperature System Failure due to: loss of electrical power failure of temperature control and air circulation systems unusual weather event Product loss Out-of-range cold or hot areas; Product storage temperature excursion; Product loss

12 Identified Risk RISK Receive an adulterated, falsified, recalled product Receive some product that was not ordered Mix-up of products with different status (Rejected/Recalled/Returned) Receiving/Shipping EFFECT Introduction into legitimate supply chain a product that is potentially substandard, illegal or counterfeited Unmatched transaction (e.g. wrong paper work/transaction data sent) Introduction into legitimate supply chain a product that is potentially substandard, illegal or counterfeited Shipping/selling of inappropriate product Shipping/Receiving delays due to inclement weather, natural disasters, traffic disruption Arrival delays Temperature out of specification (Temperature excursions, e.g. accidentally freezing when is snowing)

13 Risk-based Approach to Storage and Transportation Quality Management System Documentation Training Qualification/Validation Instructions, Schedules and Records INFORMATION Competence Development and Instructions Understanding COMPREHENSION Ensure suitability of the purpose Warehouse/Packaging System/Transportation ASSURANCE Mitigation Strategies Resources Capability through infrastructure and human resources MATERIALS Risk Identification The central idea is having a Quality System that is build based on risk. Generally, mitigation strategies are related to instructions (SOPs), training (ensure instructions understanding) and Qualification/Validation (warehouse temp map, packaging system, ERP software, process validation (in case of distribution, is the transport mode/route validation).

14 Mitigation Strategies Mitigation strategies fall within categories and are related to: Documentation: instructions for a specific operation or process in order to standardize and establish consistency Training: ensuring instructions are understood Qualification/Validation: the assurance that the processes and instrumentation are reliable, reproducible and robust. Resources: having capability through infrastructure and human resources (infrastructure and human)

15 Mitigation Strategies: Documentation Key documents that are fundamental for a QMS that supply chain partners can implement in their organizations: Quality Manual Standard Operating Procedures (SOPs) Recalls Returns Receiving Storage and Transportation Supplier Qualification Labels Quality Agreements Excursion Handling

16 Mitigation Strategies: Qualification/Validation Action Temperature Recording Devices Used for Temperature Mapping or Temperature Recording for Storage and Transportation Qualification (Facilities, Equipment, Thermal Packaging and Transportation Systems) Validation (Processes and Procedures) Calibration (Instruments or Devices) Manufacturers, Repackagers, Distributors, and Pharmacies Packaging designed to maintain temperature sensitive product within specific temperature ranges Manufacturers, Repackagers, Distributors, and Pharmacies (if shipping) Placement of Temperature Recording Devices within a storage area to monitor / record Temperature Manufacturers, Repackagers, Distributors, and Pharmacies (if shipping) Transportation Vehicles Manufacturers, Repackagers, Distributors, and Pharmacies(if shipping) Software or website verification of output Manufacturers & Repackages

17 Mitigation Strategies: Training / Resources Training is a critical process to communicate job expectations and to develop skills to effectively and efficiently execute daily responsibilities. Training should be covered in a training SOP Training may be: Instruction led by qualified instructors or subject-matter experts On-the-job training by a supervisor or other qualified personnel Web-based training or simulations. Training effectiveness determined Resources are storage, transportation and personnel. Storage Premises should be designed to maintain the quality and integrity of drug product stored Transportation All vehicles used in supply chain activities, such as semitrailer trucks, vans, trucks, trains, airplanes, sea vessels, mail delivery vehicles, and emergency medical services, should be suitable for the intended purpose. Personnel

18 Risk-based Approach to Storage and Transportation Quality Management System Documentation Training Qualification/Validation Instructions, Schedules and Records INFORMATION Competence Development and Instructions Understanding COMPREHENSION Ensure suitability of the purpose Warehouse/Packaging System/Transportation ASSURANCE Mitigation Strategies Resources Capability through infrastructure and human resources MATERIALS Risk Identification The central idea is having a Quality System that is build based on risk. Generally, mitigation strategies are related to instructions (SOPs), training (ensure instructions understanding) and Qualification/Validation (warehouse temp map, packaging system, ERP software, process validation (in case of distribution, is the transport mode/route validation).

19 Risks and Mitigation Strategies RISK EFFECT MITIGATION STRATEGY Improper entry to ERP-like systems: (wrong batch number, wrong expiration date, wrong status e.g. approved product that should be quarantined); wrong amount) Product has been stored in the wrong physical location Cannot have an accurate information of the stock Can pick and ship a product that was supposed to be quarantined but due to wrong status was marked as approved Picking issue mistakes (software will show the location however you can pick the wrong product if there is no check of physical placement) Product can face excursions Legal sanctions for Controlled Substance Risk of diversion for Controlled Substance Storage Stocking SOP Software validation Stocking SOP Automated checking system SOP that shows a list of products and their Temperature Specification SOP that shows a list of products and their license category (controlled, radiopharmaceuticals, etc.) MITIGATION CATEGORY/ AVENUE Documentation and Validation Documentation and Validation Documentation Documentation

20 Risks and Mitigation Strategies RISK EFFECT MITIGATION STRATEGY Environmental conditions out of specification Affects product quality, integrity and patient safety (e.g. freezing of vaccine or biologic) Storage Warehouse, packaging and transportation qualification (temperature mapping) MITIGATION CATEGORY/ AVENUE Qualification/Validation Documentation Temperature Monitoring Device Failure Product loss (e.g. money) Out-of-range cold or hot areas; Product storage temperature excursion; Product storage identification Back-up monitoring devices with independent power source Excursion handling SOP Documentation/Resources Storage /Temperature System Failure due to: loss of electrical power failure of temperature control and air circulation systems unusual weather event Product loss Out-of-range cold or hot areas; Product storage temperature excursion; Product loss Temperature and power alarms, Back-up power and coolant systems (redundant) and/or contingency storage; Excursion handling SOP Documentation/Resources

21 Risks and Mitigation Strategies Receive an adulterated, falsified, recalled product RISK EFFECT MITIGATION STRATEGY Receive some product that was not ordered Introduction into legitimate supply chain a product that is potentially substandard, illegal or counterfeited Unmatched transaction (e.g. wrong paper work/transaction data sent) Introduction into legitimate supply chain a product that is potentially substandard, illegal or counterfeited Receiving/Shipping Quarantine Quality Control test Packaging identification fingerprints Recall awareness Notify regulatory authorities or trading partners Receiving SOP and training MITIGATION CATEGORY/ AVENUE Documentation Documentation and Training

22 Risks and Mitigation Strategies RISK EFFECT MITIGATION STRATEGY Mix-up products with different status (Rejected/Recalled/Returned) Shipping/selling of inappropriate product Receiving/Shipping Product segregation Warehouse layout (logical flow and holding areas in order to avoid mix ups) MITIGATION CATEGORY/ AVENUE Documentation and Resources Shipping/Receiving delays due to inclement weather, natural disasters, traffic disruption Arrival delays Temperature out of specification (Temperature excursions, e.g. accidentally freezing when is snowing) Receiving SOP Reschedule the delivery Temporary parking (waiting for availability to unload). This could mean offloading to temperature controlled facility or vehicle Documentation Recondition materials to ensure temperature maintenance during delay Rescue Services

23 Role of Supply Chain Members Some Applicable Mitigation Strategies Manufacturer Role of the Organization within the Supply Chain Wholesaler Pharmacy/ Hospital/Health Brokers distributor Compounding care providers Pharmacy Freight Forwarders Documentation (Manuals, Procedures, Protocols, Records) Quality Manual Yes Yes Yes Yes Yes Yes Labeling Yes Yes Yes Yes No No Procurement Yes Yes Yes Yes Yes Yes Receiving Yes Yes Yes Yes No Yes Picking Yes Yes Yes Yes No Yes Packing Yes Yes Yes No No No Sales Yes Yes Yes No Yes No Storage Yes Yes Yes Yes No Yes Transportation Yes Yes Yes No 1 No Yes Supplier Qualification Yes Yes Yes Yes Yes Yes Customer Qualification Yes Yes No No Yes Yes Quality Agreements Yes Yes Yes Yes Yes Yes Licenses and Authorizations Yes Yes Yes Yes Yes Yes Recall Yes Yes Yes Yes Yes Yes Return Yes Yes Yes Yes No No Temporary parking No No No No No Yes Excursion handling Yes Yes Yes Yes No Yes Disposal of expired and rejected drug product Yes Yes Yes Yes No Yes Pest Control and Pallet Conservation Yes Yes Yes Yes No Yes

24 Role of Supply Chain Members Some Applicable Mitigation Strategies Manufacturer Wholesaler distributor Role of the Organization within the Supply Chain Pharmacy/ Hospital/Health Brokers Compounding care providers Pharmacy Freight Forwarders Training Yes Yes Yes Yes Yes Yes Resources Product segregation Yes Yes Yes Yes No Yes Storage area (layout/logical flow) Yes Yes Yes Yes No Yes 2 Maintenance Yes Yes Yes Yes No Yes Calibration Yes Yes Yes Yes No Yes Monitoring Systems and Alarms Yes Yes Yes Yes No Yes Appropriate number of personnel Yes Yes Yes Yes Yes Yes Organizational chart/job descriptions Yes Yes Yes Yes Yes Yes Qualification/Validation Temperature Mapping Yes Yes Yes Yes No Yes Shipping Packaging qualification Yes Yes Yes No 1 No No Software validation (automated checking systems, ERPs, ERP-like systems) Yes Yes Yes Yes Yes Yes

25 Conclusion Product and process knowledge is the starting point in identifying risks related to the storage and transportation The mitigation strategies should be put in place to off set the risk related to storage and transportation The mitigation strategies can be divided into four essentials pillars: Documentation Training Qualification/Validation Resources Identifying storage and transportation risk and putting in place the appropriate mitigation strategies will enhance quality assured processes, maintain product quality and supply chain integrity.

26

Taking a Leap Toward Global Supply Chain Efficiency - Part II

Taking a Leap Toward Global Supply Chain Efficiency - Part II Taking a Leap Toward Global Supply Chain Efficiency - Part II 2 Supply Chain Brochure - Part II INTRODUCTION Pharmaceutical manufacturers face a number of challenges in the production and delivery of medicinal

More information

<1079> GOOD STORAGE AND SHIPPING PRACTICES-General Chapters

<1079> GOOD STORAGE AND SHIPPING PRACTICES-General Chapters US. Pharmacopoeia USP29 GOOD STORAGE AND SHIPPING PRACTICES-General Chapters 1079 GOOD STORAGE AND SHIPPING PRACTICES This general information chapter is intended to provide general guidance concerning

More information

Code of Practice for Holder of Certificate of Registration as an Importer and Exporter of Pharmaceutical Products

Code of Practice for Holder of Certificate of Registration as an Importer and Exporter of Pharmaceutical Products Code of Practice for Holder of Certificate of Registration as an Importer and Exporter of Pharmaceutical Products March 2014 Table of Content INTRODUCTION 3 Section 1: GENERAL RESPONSIBILITIES OF HOLDER

More information

Summary of Proposed USP General Chapter <1083> Good Distribution Practices Supply Chain Integrity 02/15/2012

Summary of Proposed USP General Chapter <1083> Good Distribution Practices Supply Chain Integrity 02/15/2012 Summary of Proposed USP General Chapter Good Distribution Practices Supply Chain Integrity 02/15/2012 This summary was prepared by the Rx-360 Monitoring and Reporting Working Group which tracks

More information

QS, GDP (+GMP?) Maintaining the Integrity of The Supply Chain

QS, GDP (+GMP?) Maintaining the Integrity of The Supply Chain QS, GDP (+GMP?) Maintaining the Integrity of The Supply Chain Presented by: Karen Ginsbury For IFF 01 March, 2017 Pharma Supply Chain Manufacturer Wholesaler Raw Material Supply Production Transport Warehouse

More information

Mary G. Foster, PharmD, USP Chair Packaging, Storage & Distribution Expert Committee June 9, 2015, San Francisco

Mary G. Foster, PharmD, USP Chair Packaging, Storage & Distribution Expert Committee June 9, 2015, San Francisco AAPS Mini Symposium Frozen State Storage and Cold Chain Transportation Storage & Shipping of Biopharmaceuticals USP General Chapter Good Distribution Practices Latest Guidance Developments Mary

More information

Overview sulla nuova guideline GDP

Overview sulla nuova guideline GDP AFTI 09 febbraio 2012 Overview sulla nuova guideline GDP Fabio Dotto Ispettorato Regionale Medicamenti Svizzera del Sud 1 113 GDP Guidelines GDP of Medicinal Products for Human Use Public consultation

More information

Aide-Memoire on Product Return: A Risk-based Rationale for Inspecting Returns and its Impacts on GDP Compliance Assessment

Aide-Memoire on Product Return: A Risk-based Rationale for Inspecting Returns and its Impacts on GDP Compliance Assessment Aide-Memoire on Product Return: A Risk-based Rationale for Inspecting Returns and its Impacts on GDP Compliance Assessment Glaucia Karime Braga, Ph.D. USP Packaging and Distribution Expert Committee Member

More information

USP General Chapter <1079> Pharmacopeia Forum. for Drug Products

USP General Chapter <1079> Pharmacopeia Forum. for Drug Products USP General Chapter Pharmacopeia Forum Good Storage and Transportation Practices for Drug Products IATA Vancouver/March 8-12, 2010 Mary Foster, PharmD USP Expert Committee Member, 2005-2010 2010

More information

Corso di Laurea Magistrale in Chimica e Tecnologia Farmaceutiche E25

Corso di Laurea Magistrale in Chimica e Tecnologia Farmaceutiche E25 Sezione di Tecnologia e Legislazione Farmaceutiche Maria Edvige Sangalli Corso di Laurea Magistrale in Chimica e Tecnologia Farmaceutiche E25 Fabbricazione Industriale dei Medicinali 4 CFU Supply Chain

More information

BSWH Technician Continuing Education 2016 Part 2: Pharmacy Law - Controlled Substance Security & Drug Supply Chain Security Act (DSCSA) Contact

BSWH Technician Continuing Education 2016 Part 2: Pharmacy Law - Controlled Substance Security & Drug Supply Chain Security Act (DSCSA) Contact BSWH Technician Continuing Education 2016 Part 2: Pharmacy Law - Controlled Substance Security & Drug Supply Chain Security Act (DSCSA) Contact Hours: 1.5 Objectives List some strategies regarding safe

More information

Presse-Information Press release Information de presse

Presse-Information Press release Information de presse Presse-Information Press release Information de presse Kontakt/Contact: Dr. Kathrin Rübberdt Tel. ++49 (0) 69 / 75 64-2 77 Fax ++49 (0) 69 / 75 64-2 72 e-mail: presse@dechema.de Trend Report February 2018

More information

GLOBAL HEALTH SUPPLY CHAIN QUALITY ASSURANCE QA.APP.GEN-52 Laboratory Commodities and Consumables: Supplier Technical Questionnaire

GLOBAL HEALTH SUPPLY CHAIN QUALITY ASSURANCE QA.APP.GEN-52 Laboratory Commodities and Consumables: Supplier Technical Questionnaire GLOBAL HEALTH SUPPLY CHAIN QUALITY ASSURANCE Laboratory Commodities and Consumables: Supplier Technical Questionnaire This questionnaire is used to collect information from offerors of Laboratory Commodities

More information

GUIDELINES ON THE PRINCIPLES OF GOOD DISTRIBUTION PRACTICE OF ACTIVE SUBSTANCES FOR MEDICINAL PRODUCTS FOR HUMAN USE

GUIDELINES ON THE PRINCIPLES OF GOOD DISTRIBUTION PRACTICE OF ACTIVE SUBSTANCES FOR MEDICINAL PRODUCTS FOR HUMAN USE PHARMACEUTICAL INSPECTION CONVENTION PHARMACEUTICAL INSPECTION CO-OPERATION SCHEME PI 047-1 Annex 1 July 2018 GUIDELINES ON THE PRINCIPLES OF GOOD DISTRIBUTION PRACTICE OF ACTIVE SUBSTANCES FOR MEDICINAL

More information

(Information) INFORMATION FROM EUROPEAN UNION INSTITUTIONS, BODIES, OFFICES AND AGENCIES EUROPEAN COMMISSION

(Information) INFORMATION FROM EUROPEAN UNION INSTITUTIONS, BODIES, OFFICES AND AGENCIES EUROPEAN COMMISSION 21.3.2015 EN Official Journal of the European Union C 95/1 II (Information) INFORMATION FROM EUROPEAN UNION INSTITUTIONS, BODIES, OFFICES AND AGENCIES EUROPEAN COMMISSION Guidelines of 19 March 2015 on

More information

Logistic Provider Qualification: prerequisites and SLA

Logistic Provider Qualification: prerequisites and SLA Logistic Provider Qualification: prerequisites and SLA Summary of the Content Benchmarking comparable providers and services to cope with product and market requirements Pre-qualification Activities Operational

More information

Guidelines on Good Distribution Practice of Medicinal Products for Human Use. CF edition

Guidelines on Good Distribution Practice of Medicinal Products for Human Use. CF edition Introduction Introduction These guidelines have been prepared in accordance with Article 10 of Council The present guidelines are based on Articles 84 and 85a(3) of Directive Directive 92/25/EEC of 31

More information

Feedback from Inspection Programme

Feedback from Inspection Programme Feedback from Inspection Programme Wholesale Distribution Conference 8 th February 2017 Darren Scully Health Products Distribution Manager Wholesale distribution overview wholesale distribution procure

More information

Counterfeit Pharmaceuticals Supply Chain

Counterfeit Pharmaceuticals Supply Chain Counterfeit Pharmaceuticals Supply Chain Session 168 February 13, 2019 Alanna Lavelle, Senior Principal, MITRE Corporation Cathy Begley, Executive Director, Merck 2019 The MITRE Corporation All Rights

More information

Commission Guidelines on Good Distribution Practice of Medicinal Products for Human Use

Commission Guidelines on Good Distribution Practice of Medicinal Products for Human Use EUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL Public Health and Risk Assessment Pharmaceuticals Brussels, SANCO/C8/AM/an D(2010) 380358 Commission Guidelines on Good Distribution Practice

More information

Counterfeit Drugs and Supply Chain Security

Counterfeit Drugs and Supply Chain Security Counterfeit Drugs and Supply Chain Security Rick Mitzner Senior Director, Engineering Technology Pfizer, Inc. Interphex April 21, 2015 Tragic Consequences Not If But When and Where May 7, 2007 80 children

More information

GUIDELINES ON GOOD DISTRIBUTION PRACTICES FOR PHARMACEUTICAL PRODUCTS

GUIDELINES ON GOOD DISTRIBUTION PRACTICES FOR PHARMACEUTICAL PRODUCTS DRAFT VERSION GUIDELINES ON GOOD DISTRIBUTION PRACTICES FOR PHARMACEUTICAL PRODUCTS Published on the website of www.cdsco.nic.in on 10/01/2013 Notification The following draft guideline is hereby published

More information

Good Manufacturing Practices. Single Points of Contact. Surveillance and Monitoring. Good Distribution Practices. Track and Trace System

Good Manufacturing Practices. Single Points of Contact. Surveillance and Monitoring. Good Distribution Practices. Track and Trace System Single Points of Contact Good Manufacturing Practices Surveillance and Monitoring Good Distribution Practices 10 1 9 Track and Trace System 2 8 3 7 Good Import/ Export Practices 4 6 5 Internet Sales Clinical

More information

Management System Hilton Olympia, London 13 th February 2013

Management System Hilton Olympia, London 13 th February 2013 14. Building A Robust Quality Management System Hilton Olympia, London 13 th February 2013 Calcott Consulting consultant to the pharmaceutical & biotechnology industry Presenter s note Please note, the

More information

Re: Proposed revisions to USP General Chapter <1079> Good Storage and Distribution Practices For Drug Products

Re: Proposed revisions to USP General Chapter <1079> Good Storage and Distribution Practices For Drug Products 30 September 2011 Scientific Liaison (PS05) Packaging and Storage Expert Committee US Pharmacopeia 12601 Twinbrook Pkwy Rockville MD 20852-1790 Re: Proposed revisions to USP General Chapter Good

More information

Good Distribution Practices Toolkit. Quality Management System 08 March 2016

Good Distribution Practices Toolkit. Quality Management System 08 March 2016 Good Distribution Practices Toolkit Quality Management System 08 March 2016 1 Quality Policy GDP, Legal, Environmental, H&S Processes & Systems Resources Risk Assessments 2 Quality Policy & Objectives

More information

A PROCESS VALIDATION GUIDE FOR COLD CHAIN LOGISTICS: ENSURING COMPLIANCE GLOBALLY

A PROCESS VALIDATION GUIDE FOR COLD CHAIN LOGISTICS: ENSURING COMPLIANCE GLOBALLY A PROCESS VALIDATION GUIDE FOR COLD CHAIN LOGISTICS: ENSURING COMPLIANCE GLOBALLY Presented by: Gary Hutchinson, President, Modality Solutions 8 th BSMA Conference Preparing the Biotech Supply Chain for

More information

Product serialization and traceability mandates. kpmg.com

Product serialization and traceability mandates. kpmg.com Product serialization and traceability mandates kpmg.com 1 Product serialization and traceability mandates Increasing threats to patient safety from counterfeited, adulterated, and diverted pharmaceutical

More information

YOUR TRANSPORTATION CO.

YOUR TRANSPORTATION CO. For fast dependable Transportation Services YOUR TRANSPORTATION CO. Compliments of Marc T. Smith CAYMAN SYSTEMS INTERNATIONAL Specializing in Small & Medium Business Compliance Help e-mail to:cayman@qs9000.com

More information

Pharma and Logistic Service Providers (LSP) Synergies and opportunities GDP, NEW EUROPEAN DIRECTIVES

Pharma and Logistic Service Providers (LSP) Synergies and opportunities GDP, NEW EUROPEAN DIRECTIVES Pharma and Logistic Service Providers (LSP) Synergies and opportunities GDP, NEW EUROPEAN DIRECTIVES DB Schenker Healthcare Conference Europe April 17-18 th 2012 J. BERLO Industrial Pharmacist/Clin. Biol.

More information

Scanned by CamScanner

Scanned by CamScanner Scanned by CamScanner TABLE OF CONTENTS Part I: GUIDELINES FOR GOOD STORAGE PRACTICES Part II: GUIDELINES FOR GOOD DISTRIBUTION PRACTICES Part III: PHARMACEUTICAL PRODUCTS RECALL GUIDELINES FOOD, MEDICINE

More information

Quality Systems and GMPin Pharmaceutical Manufacturing. Marleine Akl Quality Assurance Algorithm SAL

Quality Systems and GMPin Pharmaceutical Manufacturing. Marleine Akl Quality Assurance Algorithm SAL Session s Outline 1. Bio-equivalence 2. A 30-minute DVD on GMP Break 3. Quality Systems and GMPs in Pharmaceutical Manufacturing 4. Good Distribution Practices 5. Questionnaire (could not go through due

More information

Wholesaling & Distribution & the GMPs

Wholesaling & Distribution & the GMPs Wholesaling & Distribution & the GMPs Presented by Bryan Wright 11 th July 2016 Overview Wholesaling & distribution of Medicines (FPs) in the EU New EU GDP Guidelines Expectations How complicated can the

More information

Wholesaling & Distribution & the GMPs

Wholesaling & Distribution & the GMPs Wholesaling & Distribution & the GMPs Presented by Bryan Wright 11 th July 2016 Overview Wholesaling & distribution of Medicines (FPs) in the EU New EU GDP Guidelines Expectations How complicated can the

More information

Building Effective National Strategies to Better Address Counterfeit Medicines

Building Effective National Strategies to Better Address Counterfeit Medicines Building Effective National Strategies to Better Address Counterfeit Medicines Expanding GMP, GDP, GPP, and Pharmacovigilance Systems ILISA B.G. BERNSTEIN, Pharm.D., J.D. Director of Pharmacy Affairs U.S.

More information

Reducing Risk and Costs in the Global Supply Chain

Reducing Risk and Costs in the Global Supply Chain Reducing Risk and Costs in the Global Supply Chain Global Quality & Compliance Services for the Life Sciences Industry sensitech.com @sensitech Protecting the Life Sciences Supply Chain Can Be Costly Maintaining

More information

SITE MASTER FILE For MHRA

SITE MASTER FILE For MHRA ABC CO., LTD. For MHRA Prepared by Date Approved by Date Verified by Date Document No.: SMF, Version No: 01, Effective Date: 09/05/06 Document No.: SMF Version No.: 01 Effective Date: 09/05/06 Page 2 of

More information

UNICEF s Quality Assurance System for Procurement of Finished Pharmaceutical Products

UNICEF s Quality Assurance System for Procurement of Finished Pharmaceutical Products UNICEF s Quality Assurance System for Procurement of Finished Pharmaceutical Products UNICEF Industry Consultation with Manufacturers and Suppliers of Finished Pharmaceutical Products 29 th 30 th September

More information

Healthcare Good Distribution Practice (GDP)

Healthcare Good Distribution Practice (GDP) Healthcare Good Distribution Practice (GDP) 10 March 2018 Copyright silverbacklogistics.com. All rights reserved The place to go for free supply chain advice 1 The role of the MHRA Ensuring that medicines

More information

Food Defense Supplier Guidelines

Food Defense Supplier Guidelines Food Defense Supplier Guidelines Revised: May 2015 Table of Contents Introduction 3 1. Program administration 3 a. Plan management 3 b. Roles and responsibilities 3 c. Reporting procedures 3 d. Self-assessments

More information

PROPOSAL FOR REVISION OF WHO GOOD DISTRIBUTION PRACTICES FOR PHARMACEUTICAL PRODUCTS

PROPOSAL FOR REVISION OF WHO GOOD DISTRIBUTION PRACTICES FOR PHARMACEUTICAL PRODUCTS September 2009 RESTRICTED PROPOSAL FOR REVISION OF WHO GOOD DISTRIBUTION PRACTICES FOR PHARMACEUTICAL PRODUCTS (INCLUDING MEASURES AGAINST PENETRATION OF COUNTERFEITS INTO THE LEGITIMATE SUPPLY CHAIN)

More information

Dr. Abdulrahman Mohammad Al Jassmi Chief Executive Officer Dubai Hospital Dubai Health Authority

Dr. Abdulrahman Mohammad Al Jassmi Chief Executive Officer Dubai Hospital Dubai Health Authority CHALLENGES AND OPPORTUNITIES IN COLD CHAIN: HEALTH CARE RELATED DRIVERS Dr. Abdulrahman Mohammad Al Jassmi Chief Executive Officer Dubai Hospital Dubai Health Authority AGENDA Integrating stakeholders

More information

25 February 2010 Slide 1

25 February 2010 Slide 1 Cold chain Wholesale Distribution Information Day, 25/2/2010 Greg McGurk Executive Inspector 25 February 2010 Slide 1 Cold Chain Scope: Factors affecting transportation Small scale transportation Large

More information

MINISTRY OF HEALTH ORDINANCE

MINISTRY OF HEALTH ORDINANCE MINISTRY OF HEALTH 1800 Pursuant to Article 114, paragraph 2, Article 120, paragraph 3 and Article 127 of the Medicinal Products Act (Official Gazette 76/2013), the Minister of Health hereby issues the

More information

Annex 4. Assessment tool based on the model quality assurance system for procurement agencies: aide memoire for inspection

Annex 4. Assessment tool based on the model quality assurance system for procurement agencies: aide memoire for inspection Annex 4 Assessment tool based on the model quality assurance system for procurement agencies: aide memoire for inspection 1. Introduction 294 2. Purpose 294 3. Scope 294 4. Assessment tool 295 293 WHO

More information

Pharma Market Growth and The Cost of Doing Business

Pharma Market Growth and The Cost of Doing Business Pharma Market Growth and The Cost of Doing Business May X, 2010 Agenda Pharma Market Overview Pharma Market Trends Cold Chain Complexities Freight Overview Pharma Costs and the Cost of Loss and Excursions

More information

ECIA Distributor Counterfeit Product Mitigation Internal Audit Checklist

ECIA Distributor Counterfeit Product Mitigation Internal Audit Checklist ECIA Publication ECIA Distributor Counterfeit Product Mitigation Internal Audit Checklist Based on SAE s AS6496 - Fraudulent/Counterfeit Electronic Parts: Avoidance, Detection, Mitigation, and Disposition

More information

New GDP Guidelines - Implementation

New GDP Guidelines - Implementation New GDP Guidelines - Implementation Alfred Hunt, Inspector Wholesale Distribution Conference 11 th November 2014 New GDP Guidelines 2013/C 63/01-8 th September 2013 2013/C 343/01-5 th November 2013 2 1994

More information

Timeline for the Drug Supply Chain and Security Act

Timeline for the Drug Supply Chain and Security Act April 2014 Timeline for the Drug Supply Chain and Security Act (Title II, Drug Quality and Security Act, 2013) Overview The Drug Supply Chain and Security Act (Title II, Drug Quality and Security Act,

More information

EUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL VERSION 1.0. Changes compared to superseded version:

EUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL VERSION 1.0. Changes compared to superseded version: Ref. Ares(2014)968163-28/03/2014 EUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL Health systems and products Medicinal products quality, safety and efficacy Brussels, GOOD DISTRIBUTION PRACTICE

More information

SUPPLY CHAIN SECURITY MAINTAINING INTEGRITY OF YOUR SUPPLY CHAIN

SUPPLY CHAIN SECURITY MAINTAINING INTEGRITY OF YOUR SUPPLY CHAIN SUPPLY CHAIN SECURITY MAINTAINING INTEGRITY OF YOUR SUPPLY CHAIN WORKSHOP 28 August 2017 Tony Zook Why is this important? http://www.cbsnews.com/news/fda-warns-about-fake-avastin-again/ 2 Why is this important?

More information

GUIDELINES ON THE IMPORT AND EXPORT OF REGISTERED MEDICINES

GUIDELINES ON THE IMPORT AND EXPORT OF REGISTERED MEDICINES GUIDELINES ON THE IMPORT AND EXPORT OF REGISTERED MEDICINES 1.0 INTRODUCTION 1.1. PREAMBLE The Medicines Control Authority of Zimbabwe (MCAZ) is a regulatory body established by the Medicines and Allied

More information

ABSTRACT INTERNATIONAL LOGISTICS CRITERIA ON MEDICINAL PRODUCTS FOR HUMAN USE 1. INTRODUCTION. Shiang-Min Meng 1+ Hsiu-Yun Yang 2 Jane Dai 3

ABSTRACT INTERNATIONAL LOGISTICS CRITERIA ON MEDICINAL PRODUCTS FOR HUMAN USE 1. INTRODUCTION. Shiang-Min Meng 1+ Hsiu-Yun Yang 2 Jane Dai 3 International Journal of Asian Social Science ISSN(e): 2224-4441 ISSN(p): 2226-5139 DOI: 10.18488/journal.1.2019.92.148.168 Vol. 9, No. 2, 148-168 URL: www.aessweb.com INTERNATIONAL LOGISTICS CRITERIA

More information

Quality Risk Management (QRM) of active pharmaceutical ingredients during transportation by using FMEA tools and methodology

Quality Risk Management (QRM) of active pharmaceutical ingredients during transportation by using FMEA tools and methodology PharmaTutor PRINT ISSN: 294-6679 E-ISSN: 247-788 2 Quality Risk Management (QRM) of active pharmaceutical ingredients during transportation by using FMEA tools and methodology Upendra Kumar Singh*, Sammer

More information

MHRA GDP Symposium. Novotel London West, London 8 & 10 December #GMDPevents

MHRA GDP Symposium. Novotel London West, London 8 & 10 December #GMDPevents MHRA GDP Symposium Novotel London West, London 8 & 10 December 2015 Deficiencies in GDP Phil Neale, GDP Operations Manager Tony Orme, GDP Senior Inspector. Finding deficiencies in GDP is not only for those

More information

Review of HPRA Draft Guide to Distribution of Medical Devices, including in vitro diagnostic Medical Devices

Review of HPRA Draft Guide to Distribution of Medical Devices, including in vitro diagnostic Medical Devices Review of HPRA Draft Guide to Distribution of Medical Devices, including in vitro diagnostic Medical Devices Ref: IA-G0004-x Summary DCC Vital welcomes the new draft guidance which will provide clarity

More information

Decree of General Administration of Quality Supervision, Inspection. and Quarantine of the People s Republic of China. No. 135

Decree of General Administration of Quality Supervision, Inspection. and Quarantine of the People s Republic of China. No. 135 Decree of General Administration of Quality Supervision, Inspection and Quarantine of the People s Republic of China No. 135 The Administrative Measures of Inspection, Quarantine and Supervision on Import

More information

MDS-G25. Guidance on Requirements for Storage, Handling and Transportation of Medical Devices

MDS-G25. Guidance on Requirements for Storage, Handling and Transportation of Medical Devices MDS-G25 Guidance on Requirements for Storage, Handling and Transportation of Medical Devices Version Number: 1.0 Version Date: 10/4/2018 This guidance document has been published after being distributed

More information

Drug Supply Chain Security Act Implementation Track and Trace Issues in 2017

Drug Supply Chain Security Act Implementation Track and Trace Issues in 2017 Drug Supply Chain Security Act Implementation Track and Trace Issues in 2017 ILISA BG BERNSTEIN, PharmD, JD Deputy Director, Office of Compliance FDA/CDER Presented at: FDLI DQSA Conference November 15,

More information

GUIDELINES FOR REGISTRATION OF IMPORTERS AND FOR THE IMPORTATION OF MEDICINES AND RELATED PRODUCTS

GUIDELINES FOR REGISTRATION OF IMPORTERS AND FOR THE IMPORTATION OF MEDICINES AND RELATED PRODUCTS MEDICINES CONTROL AGENCY 54 Kairaba Avenue, Pipeline, The Gambia. Tel.no. +220 4380632 GUIDELINES FOR REGISTRATION OF IMPORTERS AND FOR THE IMPORTATION OF MEDICINES AND RELATED PRODUCTS Document no: MCA/IMPG/2017/1

More information

NSK Steering Systems America

NSK Steering Systems America PAGE NO: 1 of 13 NSK Steering Systems America Supplier Logistics and Packaging Manual PAGE NO: 2 of 13 Table of Contents 1 Scope... 3 1.1 General... 3 2 Communication... 3 2.1 Supplier contacts... 3 2.2

More information

Quality Risk Management: Excipients

Quality Risk Management: Excipients Quality Risk Management: Excipients ExcipientFest 2012 Presented by: Londa Ritchey, M.S. Director, Supplier Qualification Global Quality Operations Pfizer, Inc. Agenda Regulatory Environment Material Quality

More information

Rules relating to what constitutes good pharmacy practice

Rules relating to what constitutes good pharmacy practice STAATSKOERANT, 27 FEBRUARIE 2015 No. 38511 13 BOARD NOTICE 50 OF 2015 THE SOUTH AFRICAN PHARMACY COUNCIL RULES RELATING TO GOOD PHARMACY PRACTICE The South African Pharmacy Council herewith publishes amendments

More information

Delivery of materials (usually finished product from a distribution center) to a first paying customer external to Site

Delivery of materials (usually finished product from a distribution center) to a first paying customer external to Site Title: Cold Chain Management of Biopharmaceutical Materials Guidance Number: 122 Prepared by: Date: Supersedes: Checked by: Date: Date Issued: Approved by: Date: Review Date: Introduction The risk of compromising

More information

WHO GLOBAL BENCHMARKING TOOL (GBT) FOR EVALUATION OF NATIONAL REGULATORY SYSTEM OF MEDICAL PRODUCTS

WHO GLOBAL BENCHMARKING TOOL (GBT) FOR EVALUATION OF NATIONAL REGULATORY SYSTEM OF MEDICAL PRODUCTS WHO GLOBAL BENCHMARKING TOOL (GBT) FOR EVALUATION OF NATIONAL REGULATORY SYSTEM OF MEDICAL PRODUCTS MARKET SURVEILLANCE AND CONTROL (MC): INDICATORS AND FACT SHEETS Revision VI version 1 November 2018

More information

The benchmark in cold chain. 30+ years experience in cold chain

The benchmark in cold chain. 30+ years experience in cold chain The benchmark in cold chain 30+ years experience in cold chain Why Temperature Controlled Transportation? A drug that has been temperature abused is every bit as dangerous as one that is not authentic

More information

Efficiency and Sustainability in Multi-Modal Supply Chains. Jean-Paul Rodrigue Dept. of Global Studies & Geography, Hofstra University, New York, USA

Efficiency and Sustainability in Multi-Modal Supply Chains. Jean-Paul Rodrigue Dept. of Global Studies & Geography, Hofstra University, New York, USA ITF/OECD Roundtable on Balancing efficiency and resilience in management of multimodal and sustainable supply chains, April 2018 12-13, Paris (France) Efficiency and Sustainability in Multi-Modal Supply

More information

Guide for Distributors of Medical Devices

Guide for Distributors of Medical Devices Guide for Distributors of Medical Devices IA-G0004-1 8 FEBRUARY 2018 This guide does not purport to be an interpretation of law and/or regulations and is for guidance purposes only. CONTENTS 1 SCOPE 3

More information

Supplier Oversight PQRI. September Steven Lynn, MS, CMQ/OE Vice President Global Quality Compliance Mylan

Supplier Oversight PQRI. September Steven Lynn, MS, CMQ/OE Vice President Global Quality Compliance Mylan Supplier Oversight September 2014 PQRI Steven Lynn, MS, CMQ/OE Vice President Global Quality Compliance Mylan Agenda Mylan Background Setting the Stage with a Scenario Current State Thinking Supplier Qualification

More information

Case Study: how reports of falsified medicinal products can impact wholesale distributors

Case Study: how reports of falsified medicinal products can impact wholesale distributors Case Study: how reports of falsified medicinal products can impact wholesale distributors Amy Kelly Ph.D. Wholesale Distribution Conference 11 th November 2014 Overview Legal basis Falsified medicine issues

More information

Food Defense and Emergency Response Security Guidelines. Keep America's Food Safe

Food Defense and Emergency Response Security Guidelines. Keep America's Food Safe Food Defense and Emergency Response Security Guidelines Keep America's Food Safe Note: This text version is provided to ensure accessibility. A fully illustrated, PDF version is also available. The tragic

More information

Quality Risk Management. of the GDP Supply Chain. Dr Cormac Dalton Inspector. Crowne Plaza Hotel, 25/2/2010. Date 22-Feb-10 Slide 1

Quality Risk Management. of the GDP Supply Chain. Dr Cormac Dalton Inspector. Crowne Plaza Hotel, 25/2/2010. Date 22-Feb-10 Slide 1 Quality Risk Management of the GDP Supply Chain Crowne Plaza Hotel, 25/2/2010 Dr Cormac Dalton Inspector Date 22-Feb-10 Slide 1 Supply Chain Experiment Pharmaceutical excipient ordered 3 rd December 09

More information

EUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL

EUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL Ref. Ares(2013)148102-05/02/2013 EUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL Health systems and products Medicinal products quality, safety and efficacy Brussels, SANCO/D/6/SF/mg/ddg1.d.6(2013)179367

More information

IBS Electronics, Inc.

IBS Electronics, Inc. ******************************* *** Quality Policy Manual ISO9001:2015 Uncontrolled When Printed 3506-D W. Lake Center Dr. Santa Ana, Ca 92704 U.S.A. 714.751.6633 800.527.2888 714.751.8159 FAX. E-mail:

More information

Documenta tion and Records

Documenta tion and Records Documenta tion and Records Page 1 of 30 Training Outcome of the Module: After completing this module, you will be able to: Recognize the importance of procedures Recognize the importance of record keeping

More information

Health Care Logistics: an Enabler of Change BioLogistics in a Changing Healthcare World Northwestern University Transportation Center

Health Care Logistics: an Enabler of Change BioLogistics in a Changing Healthcare World Northwestern University Transportation Center Health Care Logistics: an Enabler of Change BioLogistics in a Changing Healthcare World Northwestern University Transportation Center Dave Bode VP, Health Care Solutions DSC Logistics April 20, 2016 Health

More information

POST IMPORTATION TESTING

POST IMPORTATION TESTING POST IMPORTATION TESTING SAPRAA MEETING Karen Ford BYTES CONFERENCE CENTRE, MIDRAND 17 November 2017 Thomas Edison said : There is always a better way! 2 POST IMPORTATION TESTING EXEMPTION =PITE 3 OVERVIEW

More information

Annex 6. Good trade and distribution practices for pharmaceutical starting materials

Annex 6. Good trade and distribution practices for pharmaceutical starting materials Annex 6 Good trade and distribution practices for pharmaceutical starting materials Introduction 212 1. Quality management 213 2. Organization and personnel 214 3. Premises 215 4. Procurement, warehousing

More information

NUMBER OF EMPLOYEES TOTAL ENGINEERING MANUFACTURING QUALITY SUPPLIER IN-HOUSE SPECIAL PROCESS CAPABILITIES

NUMBER OF EMPLOYEES TOTAL ENGINEERING MANUFACTURING QUALITY SUPPLIER IN-HOUSE SPECIAL PROCESS CAPABILITIES Kearfott/ACA SUPPLIER QUALITY SYSTEM SURVEY SUPPLIER NAME SUPPLIER CODE DATE ADDRESS & ZIP CODE AREA CODE & PHONE QUALITY MANAGEMENT (NAME & TITLE) PRODUCT LINE (DESCRIBE) NUMBER OF EMPLOYEES TOTAL ENGINEERING

More information

In-State Licensee Newsletter January 2007

In-State Licensee Newsletter January 2007 LOUISIANA BOARD OF WHOLESALE DRUG DISTRIBUTORS 12046 Justice Avenue, Suite C Baton Rouge, LA 70816 Phone: 225-295-8567 Fax: 225-295-8568 Website: www.lsbwdd.org email: lsbwdd@bellsouth.net In-State Licensee

More information

SUPPLIER FOOD SAFETY ASSURANCE

SUPPLIER FOOD SAFETY ASSURANCE Chapter 12 SUPPLIER FOOD SAFETY ASSURANCE 1.0 PARTS OF A SUPPLIER FOOD SAFETY ASSURANCE PROGRAM 2.0 CHOOSING SUPPLIERS 2.1 Supplier Approval 2.2 Approved Supplier List 3.0 PRODUCT SPECIFICATIONS AND CONTROLS

More information

RECOMMENDATIONS FOR DIETARY INGREDIENT PROCESSORS

RECOMMENDATIONS FOR DIETARY INGREDIENT PROCESSORS RECOMMENDATIONS FOR DIETARY INGREDIENT PROCESSORS Facilities that manufacture 117, pack, or hold dietary supplements are subject to the regulations in 21 CFR Part 111, while those that manufacture, pack,

More information

Patients are Counting on Us: A Little Less Conversation It s Time to Act

Patients are Counting on Us: A Little Less Conversation It s Time to Act Patients are Counting on Us: A Little Less Conversation It s Time to Act Martin VanTrieste SVP Quality Amgen, Inc. PDA Missouri Valley Chapter Supply Chain Security in the Pharmaceutical Industry Thousand

More information

Model requirements for the storage and transport of time and temperature sensitive pharmaceutical products

Model requirements for the storage and transport of time and temperature sensitive pharmaceutical products Model requirements for the storage and transport of time and temperature sensitive pharmaceutical products 0 0 0 Version b SEND YOUR COMMENTS TO Dr Ümit Kartoğlu by email kartogluu@who.int or by fax +

More information

Submission of comments on Commission Guidelines on Good Distribution Practice of Medicinal Products for Human Use (SANCO/C8/AM/an D(2010) )

Submission of comments on Commission Guidelines on Good Distribution Practice of Medicinal Products for Human Use (SANCO/C8/AM/an D(2010) ) 29/12/2011 Submission of comments on Commission Guidelines on Good Distribution Practice of Medicinal Products for Human Use (SANCO/C8/AM/an D(2010) 380358) Comments from: Name of organisation or individual

More information

Prescription Product Supplier Requirements

Prescription Product Supplier Requirements Prescription Product Supplier Requirements Prescription Product Suppliers: Prescription product suppliers are those suppliers that manufacture, package, or distribute a prescription pharmaceutical (drug)

More information

U.S. Traceability: the Drug Supply Chain Security Act

U.S. Traceability: the Drug Supply Chain Security Act U.S. Traceability: the Drug Supply Chain Security Act Connie Jung, RPh, PhD Associate Director for Policy & Communications (Acting) Office of Drug Security, Integrity and Recalls Office of Compliance U.S.

More information

Drug store Excellence Audit Checklist

Drug store Excellence Audit Checklist Areas of Concern Serial Number Audited Issues References Compliance with Legal & Professional Obligations 1 The facility is certified to GSP and GDP from a reputable certification body. 2 The store must

More information

Evaluation of Counterfeit Cases Impact of FMD & GDPs. Lorraine Nolan Healthcare Products Distribution Manager

Evaluation of Counterfeit Cases Impact of FMD & GDPs. Lorraine Nolan Healthcare Products Distribution Manager Evaluation of Counterfeit Cases Impact of FMD & GDPs Wholesale Distribution Information Day, 28th September 2012 Lorraine Nolan Healthcare Products Distribution Manager Slide 1 Contents 1. Review of UK

More information

EXPERT COMMITTEE ON BIOLOGICAL STANDARDIZATION EXPERT COMMITTEE ON SPECIFICATIONS FOR PHARMACEUTICAL PREPARATIONS Geneva, 18 to 22 October 2010

EXPERT COMMITTEE ON BIOLOGICAL STANDARDIZATION EXPERT COMMITTEE ON SPECIFICATIONS FOR PHARMACEUTICAL PREPARATIONS Geneva, 18 to 22 October 2010 WHO/BS/10.2129 ENGLISH ONLY EXPERT COMMITTEE ON BIOLOGICAL STANDARDIZATION EXPERT COMMITTEE ON SPECIFICATIONS FOR PHARMACEUTICAL PREPARATIONS Geneva, 18 to 22 October 2010 Model guidance for the storage

More information

ZOLL Document Number: 90E0021 Page 6 of 50 QUALITY SYSTEM MANUAL ZOLL Document Number: 90E0021 Page 7 of 50 1 EXECUTIVE MANAGEMENT APPROVAL... 10 2 INTRODUCTION... 11 3 QUALITY SYSTEM... 12 3.1 QUALITY

More information

Pharmacy Technician H A N D B O O K

Pharmacy Technician H A N D B O O K Pharmacy Technician H A N D B O O K Top Challenges for Pharmacy Technicians As a pharmacy technician, you are a key member of the pharmacy team. You re the friendly face behind the counter. And you re

More information

GFSI BENCHMARKING REQUIREMENTS GFSI GUIDANCE DOCUMENT VERSION 7.2 PART III - AII FARMING OF FISH

GFSI BENCHMARKING REQUIREMENTS GFSI GUIDANCE DOCUMENT VERSION 7.2 PART III - AII FARMING OF FISH GFSI BENCHMARKING REQUIREMENTS GFSI GUIDANCE DOCUMENT VERSION 7.2 PART III - AII FARMING OF FISH The GFSI Benchmarking Requirements version 7.2 Part III - AII Farming of Fish Certification Programme Scope

More information

CSafe Utilization in a Quality Management System. Scott Garchar Manager - Global Business Development FedEx Custom Critical

CSafe Utilization in a Quality Management System. Scott Garchar Manager - Global Business Development FedEx Custom Critical CSafe Utilization in a Quality Management System Scott Garchar Manager - Global Business Development FedEx Custom Critical Agenda CSafe Relationship History Current State Review Quality Management System

More information

Overview of Regulatory Requirements for API and Formulations

Overview of Regulatory Requirements for API and Formulations Overview of Regulatory Requirements for API and Formulations Sangeeta Sardesai 4-Dec-2010 Definition - Regulatory Requirement The restrictions, licenses, and laws applicable to a product or business, imposed

More information

SERVICES: TEMPERATURE MAPPING STUDY

SERVICES: TEMPERATURE MAPPING STUDY SERVICES: TEMPERATURE MAPPING STUDY Temperature mapping is the process used to confirm that the whole space within cold compartments operates uniformly and consistently within a specified temperature range.

More information

Validation and Verification of Supply Chain: End-to-End Karen S Ginsbury For IVT: Workshop C 28 October :30 12:00

Validation and Verification of Supply Chain: End-to-End Karen S Ginsbury For IVT: Workshop C 28 October :30 12:00 Validation and Verification of Supply Chain: End-to-End Karen S Ginsbury For IVT: Workshop C 28 October 2014 08:30 12:00 Pangea 7 May 2014 Israel ONLY Pangea 7 May 2014 Israel ONLY Pangea 7 May 2014 Israel

More information

MAIMONIDES MEDICAL CENTER

MAIMONIDES MEDICAL CENTER MAIMONIDES MEDICAL CENTER CODE: AD-088 (Revised) ORIGINALLY ISSUED: October 2, 1990 SUBJECT: Product Safety Recall and Alert I POLICY In the event of a product safety recall or alert of a medical device

More information

The World Bank. Aide Memoire for use during GMP inspections

The World Bank. Aide Memoire for use during GMP inspections The World Bank e for use during GMP inspections The World Bank Procurement of Health Sector Goods Contact persons: 0 1. General information about the manufacturer Name of manufacturer Physical address

More information

Receive Pharmaceutical Stock

Receive Pharmaceutical Stock Level: 3 Credit value: 3 Unit aim This unit enables learners to receive and store pharmaceutical stock. This unit requires learners to show that they understand current legislation and good practice when

More information